Get started
ROCHE HLDGS AGROCHE HLDGS AGROCHE HLDGS AG

ROCHE HLDGS AG

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

RHO5 chart


Full chart

RHO5 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪205.71 B‬ CHF
Dividend yield (indicated)
3.81%
Price to earnings Ratio (TTM)
24.505
Basic EPS (TTM)
10.390 CHF
Net income (FY)
‪8.28 B‬ CHF
Revenue (FY)
‪60.49 B‬ CHF
Shares float
‪688.71 M‬
Beta (1Y)
1.15

Employees


Employees (FY)
‪103.25 K‬
Change (1Y)
−356 −0.34%
Revenue / Employee (1Y)
‪585.91 K‬ CHF
Net income / Employee (1Y)
‪80.17 K‬ CHF

About ROCHE I


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas Schinecker
Website
roche.com
Headquarters
Basel
Founded
1896
ISIN
CH0012032048
FIGI
BBG0089X2L65
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RHO5 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

RHO5 highest yielding bonds


CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051
Yield to maturity
7.23%
Maturity date
Dec 13, 2051
CHGCY5766486
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
6.09%
Maturity date
Mar 8, 2054
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044
Yield to maturity
5.98%
Maturity date
Nov 28, 2044
CHGCY3666852
Genentech, Inc. 5.25% 15-JUL-2035
Yield to maturity
5.48%
Maturity date
Jul 15, 2035
CHGCY5766485
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.36%
Maturity date
Mar 8, 2054
CHGCY5766483
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
5.19%
Maturity date
Mar 8, 2034
CHGCY5698672
Roche Holdings, Inc. FRN 13-NOV-2026
Yield to maturity
5.17%
Maturity date
Nov 13, 2026
CHGCY5766484
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
5.12%
Maturity date
Mar 8, 2034
CHGCY5317198
Roche Holdings, Inc. 2.076% 13-DEC-2031
Yield to maturity
5.10%
Maturity date
Dec 13, 2031
CHGCY5766481
Roche Holdings, Inc. 4.909% 08-MAR-2031
Yield to maturity
5.09%
Maturity date
Mar 8, 2031
CHGCY5885612
Roche Holdings, Inc. 4.592% 09-SEP-2034
Yield to maturity
5.00%
Maturity date
Sep 9, 2034

See all RHO5 bonds 

Sparks


Curated watchlists where RHO5 is featured.

See all sparks 


Check out other big names from the same industry as RHO5.

Frequently Asked Questions


The current price of RHO5 is 256.932 CHF — it has increased by 1.87% in the past 24 hours. Watch ROCHE HLDGS AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ROCHE HLDGS AG stocks are traded under the ticker RHO5.
RHO5 stock has risen by 1.57% compared to the previous week, the month change is a −16.28% fall, over the last year ROCHE HLDGS AG has showed a 14.78% increase.
We've gathered analysts' opinions on ROCHE HLDGS AG future price: according to them, RHO5 price has a max estimate of 448.00 CHF and a min estimate of 230.00 CHF. Watch RHO5 chart and read a more detailed ROCHE HLDGS AG stock forecast: see what analysts think of ROCHE HLDGS AG and suggest that you do with its stocks.
RHO5 reached its all-time high on Apr 11, 2022 with the price of 403.110 CHF, and its all-time low was 213.896 CHF and was reached on May 3, 2024. View more price dynamics on RHO5 chart.
See other stocks reaching their highest and lowest prices.
RHO5 stock is 0.70% volatile and has beta coefficient of 1.15. Track ROCHE HLDGS AG stock price on the chart and check out the list of the most volatile stocks — is ROCHE HLDGS AG there?
Today ROCHE HLDGS AG has the market capitalization of ‪205.29 B‬, it has increased by 4.83% over the last week.
Yes, you can track ROCHE HLDGS AG financials in yearly and quarterly reports right on TradingView.
ROCHE HLDGS AG is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
RHO5 earnings for the last half-year are 8.57 CHF per share, whereas the estimation was 8.40 CHF, resulting in a 1.98% surprise. The estimated earnings for the next half-year are 10.52 CHF per share. See more details about ROCHE HLDGS AG earnings.
ROCHE HLDGS AG revenue for the last half-year amounts to ‪30.65 B‬ CHF, despite the estimated figure of ‪30.78 B‬ CHF. In the next half-year revenue is expected to reach ‪31.29 B‬ CHF.
RHO5 net income for the last half-year is ‪2.02 B‬ CHF, while the previous report showed ‪6.26 B‬ CHF of net income which accounts for −67.74% change. Track more ROCHE HLDGS AG financial stats to get the full picture.
Yes, RHO5 dividends are paid annually. The last dividend per share was 9.70 CHF. As of today, Dividend Yield (TTM)% is 3.76%. Tracking ROCHE HLDGS AG dividends might help you take more informed decisions.
ROCHE HLDGS AG dividend yield was 3.80% in 2024, and payout ratio reached 93.40%. The year before the numbers were 3.93% and 66.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 24, 2025, the company has ‪103.25 K‬ employees. See our rating of the largest employees — is ROCHE HLDGS AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROCHE HLDGS AG EBITDA is ‪21.04 B‬ CHF, and current EBITDA margin is 35.81%. See more stats in ROCHE HLDGS AG financial statements.
Like other stocks, RHO5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROCHE HLDGS AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ROCHE HLDGS AG technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ROCHE HLDGS AG stock shows the sell signal. See more of ROCHE HLDGS AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.